Wagner M, Goetghebeur M, Merikle E, Pandya A, Chu P, Taylor DC. COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA. J Popl Ther Clin Pharmacol. 2018;16(2). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/549